Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis

导出原文传递

翻译打印收藏纠错

作者： Oke, Oluchi ^[1] ; Sethi, Tarsheen ^[2] ; Goodman, Stacey ^[3] ; Phillips, Sharon ^[4] ; Decker, Ilka ^[5] ; Rubinstein, Samuel ^[6] ; Concepcion, Beatrice ; Horst, Sarah ; Jagasia, Madan ; Kassim, Adetola ; Harrell, Shelton L. ; Langone, Anthony ; Lenihan, Daniel ; Rawling, Kyle T. ; Slosky, David ; Cornell, Robert Frank

作者单位： Vanderbilt Univ, Med Ctr, Div Nephrol, Nashville, TN 37232 USA ^[1] Vanderbilt Univ, Div Cardiol, Med Ctr, Nashville, TN 37232 USA ^[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA ^[3] Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN 37232 USA ^[4] Vanderbilt Univ, Med Ctr, Div Biostat & Quantitat Sci, Nashville, TN 37232 USA ^[5] Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN 37232 USA ^[6]

关键词 Light chain amyloidosis Organ response chemotherapy Bortezomib Transplantation

发布时间 2018-03-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交